Range
15.05 - 15.49
Vol / Avg.
183.4K/282.4K
Div / Yield
-
52 Wk
14.18 - 34.71
Mkt Cap
653.3M
Payout Ratio
-
Open
15.41
P/E
-
EPS
-0.28
Shares
43M
Outstanding
43M
Total Float
-
Sector: Health Care.Industry: Biotechnology
Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. The company reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-04
REV
Q1 2021Est.ActualSurprise
EPS-0.810-0.260 0.5500
REV7.800M27.966M20.166M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CLLSCellectis-0.78%653.3M

Cellectis Frequently Asked Questions

Q

How do I buy Cellectis (CLLS) stock?

A

You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Cellectis (CLLS) stock?

A

The latest price target for Cellectis (NASDAQ: CLLS) was reported by Guggenheim on April 28, 2021. The analyst firm set a price target for 0.00 expecting CLLS to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cellectis (CLLS)?

A

The stock price for Cellectis (NASDAQ: CLLS) is $15.18 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Cellectis (CLLS) pay a dividend?

A

There are no upcoming dividends for Cellectis.

Q

When is Cellectis (NASDAQ:CLLS) reporting earnings?

A
Cellectis’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is Cellectis (CLLS) going to split?

A

There is no upcoming split for Cellectis.

Q

What sector and industry does Cellectis (CLLS) operate in?

A

Cellectis is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.